149 related articles for article (PubMed ID: 37345731)
1. The spectrum and significance of secondary (co-occurring) genetic alterations in sarcomas: the hallmarks of sarcomagenesis.
Dermawan JK; Rubin BP
J Pathol; 2023 Aug; 260(5):637-648. PubMed ID: 37345731
[TBL] [Abstract][Full Text] [Related]
2. Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.
Ali NM; Niada S; Brini AT; Morris MR; Kurusamy S; Alholle A; Huen D; Antonescu CR; Tirode F; Sumathi V; Latif F
J Pathol; 2019 Feb; 247(2):166-176. PubMed ID: 30281149
[TBL] [Abstract][Full Text] [Related]
3. Undifferentiated pleomorphic sarcomas with PRDM10 fusions have a distinct gene expression profile.
Hofvander J; Puls F; Pillay N; Steele CD; Flanagan AM; Magnusson L; Nilsson J; Mertens F
J Pathol; 2019 Dec; 249(4):425-434. PubMed ID: 31313299
[TBL] [Abstract][Full Text] [Related]
4. Disruption of mammalian SWI/SNF and polycomb complexes in human sarcomas: mechanisms and therapeutic opportunities.
McBride MJ; Kadoch C
J Pathol; 2018 Apr; 244(5):638-649. PubMed ID: 29359803
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.
Jour G; Scarborough JD; Jones RL; Loggers E; Pollack SM; Pritchard CC; Hoch BL
Hum Pathol; 2014 Aug; 45(8):1563-71. PubMed ID: 24908143
[TBL] [Abstract][Full Text] [Related]
6. Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss.
Lazo de la Vega L; Hovelson DH; Cani AK; Liu CJ; McHugh JB; Lucas DR; Thomas DG; Patel RM; Tomlins SA
Hum Pathol; 2016 Dec; 58():161-170. PubMed ID: 27664537
[TBL] [Abstract][Full Text] [Related]
7. Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1-KMT2A-YAP1 and VIM-KMT2A fusions.
Massoth LR; Hung YP; Nardi V; Nielsen GP; Hasserjian RP; Louissaint A; Fisch AS; Deshpande V; Zukerberg LR; Lennerz JK; Selig M; Glomski K; Patel PJ; Williams KJ; Sokol ES; Alexander BM; Vergilio JA; Ross JS; Pavlick DC; Chebib I; Williams EA
Mod Pathol; 2020 Nov; 33(11):2307-2317. PubMed ID: 32461620
[TBL] [Abstract][Full Text] [Related]
8. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.
Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW
J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347
[TBL] [Abstract][Full Text] [Related]
9. Genetic drivers and cells of origin in sarcomagenesis.
Kannan S; Lock I; Ozenberger BB; Jones KB
J Pathol; 2021 Jul; 254(4):474-493. PubMed ID: 33428234
[TBL] [Abstract][Full Text] [Related]
10. TP53 in bone and soft tissue sarcomas.
Thoenen E; Curl A; Iwakuma T
Pharmacol Ther; 2019 Oct; 202():149-164. PubMed ID: 31276706
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma.
Suehara Y; Kohsaka S; Hayashi T; Akaike K; Kurisaki-Arakawa A; Sato S; Kobayashi E; Mizuno S; Ueno T; Morii T; Okuma T; Kurihara T; Hasegawa N; Sano K; Sasa K; Okubo T; Kim Y; Mano H; Saito T
Clin Orthop Relat Res; 2021 Apr; 479(4):838-852. PubMed ID: 33196586
[TBL] [Abstract][Full Text] [Related]
12. Mutational landscape in genetically engineered, carcinogen-induced, and radiation-induced mouse sarcoma.
Lee CL; Mowery YM; Daniel AR; Zhang D; Sibley AB; Delaney JR; Wisdom AJ; Qin X; Wang X; Caraballo I; Gresham J; Luo L; Van Mater D; Owzar K; Kirsch DG
JCI Insight; 2019 Jul; 4(13):. PubMed ID: 31112524
[TBL] [Abstract][Full Text] [Related]
13. [Grading of soft tissue and bone sarcomas].
Petersen I; Wardelmann E
Pathologe; 2016 Jul; 37(4):320-7. PubMed ID: 27384333
[TBL] [Abstract][Full Text] [Related]
14. Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets.
Kim J; Kim JH; Kang HG; Park SY; Yu JY; Lee EY; Oh SE; Kim YH; Yun T; Park C; Cho SY; You HJ
BMC Med Genet; 2018 Dec; 19(Suppl 1):216. PubMed ID: 30598078
[TBL] [Abstract][Full Text] [Related]
15. Whole-Genome Sequencing Reveals Mutational Signatures Related to Radiation-Induced Sarcomas and DNA-Damage-Repair Pathways.
Kim E; Han DJ; Kim BH; Yoo J; Kim HJ; Wu HG; Kim KS; Kim HS; Han I; Moon KC; Park JH; Song S; Kim TM; Chang JH
Mod Pathol; 2023 Jan; 36(1):100004. PubMed ID: 36788076
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical correlates of recurrent genetic alterations in sarcomas.
Anderson WJ; Hornick JL
Genes Chromosomes Cancer; 2019 Feb; 58(2):111-123. PubMed ID: 30382607
[TBL] [Abstract][Full Text] [Related]
17. The clinical relevance of molecular genetics in soft tissue sarcomas.
Ordóñez JL; Osuna D; García-Domínguez DJ; Amaral AT; Otero-Motta AP; Mackintosh C; Sevillano MV; Barbado MV; Hernández T; de Alava E
Adv Anat Pathol; 2010 May; 17(3):162-81. PubMed ID: 20418671
[TBL] [Abstract][Full Text] [Related]
18. Elucidating the transcriptional program of feline injection-site sarcoma using a cross-species mRNA-sequencing approach.
Wei Q; Ramsey SA; Larson MK; Berlow NE; Ochola D; Shiprack C; Kashyap A; Séguin B; Keller C; Löhr CV
BMC Cancer; 2019 Apr; 19(1):311. PubMed ID: 30947707
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Pathology: the 2023 Annual Review Issue of The Journal of Pathology.
Jones JL; Poulsom R; Coates PJ
J Pathol; 2023 Aug; 260(5):495-497. PubMed ID: 37580852
[TBL] [Abstract][Full Text] [Related]
20. Genomic Profiling and Clinical Outcomes of Targeted Therapies in Adult Patients with Soft Tissue Sarcomas.
Kokkali S; Georgaki E; Mandrakis G; Valverde C; Theocharis S
Cells; 2023 Nov; 12(22):. PubMed ID: 37998367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
